USPTO serial 79373011
RENOTRUE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 8, 2024
- Examiner
- OSGOOD, KRYSTINA E
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with RENOTRUE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary L.Grieco
Mary L.Grieco Olshan Frome Wolosky LLP1325 Avenue of the AmericasNew York, NY 10019United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for calculating the risk of disease; Downloadable computer software for analyzing health data for detecting disease; Downloadable computer software for analyzing health data for detecting kidney disease; Downloadable computer software for analyzing health data for health and disease prognoses; Downloadable computer software for analyzing health data for estimating and detecting kidney failure; Downloadable computer software for analyzing health data for estimating kidney filtering efficacy; Downloadable artificial neural network software for analyzing health data for detecting diseases, estimating kidney failure, estimating kidney filtering efficacy, and calculating the risk of disease; Downloadable data processing software; Downloadable data analysis software | ACTIVE | — |
| 042 | Design and development of software; Design and development of computer software featuring an online calculator for detection of disease; Software as a service (SaaS) services featuring computer software for analyzing health data for detecting diseases, estimating kidney failure, estimating kidney filtering efficacy, and calculating the risk of disease; Platform as a service (PaaS) services featuring computer software platforms for analyzing health data for detecting diseases, estimating kidney failure, estimating kidney filtering efficacy, and calculating the risk of disease; Provision of online non-downloadable software for calculating the risk of disease; Provision of online non-downloadable software for analyzing health data for detecting disease; Provision of online non-downloadable software for analyzing health data for health and disease prognoses; Provision of online non-downloadable software for analyzing health data for detecting kidney disease; Provision of online non-downloadable software for analyzing health data for estimating and detecting kidney failure; Provision of online non-downloadable software for analyzing health data for estimating kidney filtering efficacy; Provision of online non-downloadable artificial neural network software for analyzing health data for detecting diseases, estimating kidney failure, estimating kidney filtering efficacy, and calculating the risk of disease; Provision of online non-downloadable data processing software; Provision of online non-downloadable data analysis software; Medical research; Conducting medical and scientific research in the field of clinical trials; Advisory, consultancy, and information services relating to the aforesaid, namely, advisory services relating to computer software and providing information about medical research | ACTIVE | — |
| 044 | Provision of health information via an online health calculator; Medical and disease diagnostic services, namely, performing diagnosis of diseases; Health care services; Health diagnosis services, namely, performing diagnosis of diseases and performing diagnosis of risk of diseases; Health care, namely, diagnosis, prevention, treatment of disease; Health care, namely, diagnosis, prevention, treatment of diabetes; Health care, namely, diagnosis, prevention, treatment of complications associated with disease; Health care, namely, diagnosis, prevention, treatment of complications associated with diabetes; Advisory, consultancy and information services relating to the aforesaid, namely, medical advisory services, medical consultations and medical information | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by The University of Melbourne
- Other trademarks owned by The University of Melbourne
- Other trademarks owned by The University of Melbourne
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named RENOTRUE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 8, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 23, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 23, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 3, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 18, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 18, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 18, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 18, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 18, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 14, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 13, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 13, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 27, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 8, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 8, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 24, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 23, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 22, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 7, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 3, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 29, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |